SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-032911
Filing Date
2011-02-11
Accepted
2011-02-11 17:07:16
Documents
3
Period of Report
2011-02-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18983
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY dex31.htm EX-3.1 47900
3 AMENDED AND RESTATED BYLAWS OF THE COMPANY dex32.htm EX-3.2 124554
  Complete submission text file 0001193125-11-032911.txt   193190
Mailing Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 11600309
SIC: 2834 Pharmaceutical Preparations